LEXINGTON, Massachusetts , December 10, 2014 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) is hosting a Research and Development (R&D) Day for the investment community focused on the Company's pipeline of innovative medicines being developed to treat rare diseases and other specialty conditions.
New technology for pilots wirelessly delivers SiriusXM weather and other key information plus SiriusXM's wide-variety of audio entertainment when paired with Apple iPad or iPad mini
NEW YORK and ANDOVER, Mass.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Soliris ® (eculizumab)
has been granted orphan drug designation (ODD) by Japan’s Ministry of
Health, Labour and Welfare (MHLW) for the treatment of patients with
myasthenia gravis (MG), a rare, debilitating neurologic disorder.
CA Technologies (NASDAQ:CA) today announced that TAP Portugal is using CA
Application Performance Management (APM) to ensure the performance
of critical business applications and improve the experience and quality
of service provided to customers.
On the heels of Forbes
naming Abilene, Texas as one of its best places to retire , Taylor
Consulting Inc. (OTCBB:TAYO) will add more real estate agents to its
recently acquired Abilene-based broker White
Buffalo Property Solutions to meet expected increases in demand.
FedEx Freight, a subsidiary of FedEx Corp (NYSE: FDX), announced today
that the Teamsters union has withdrawn another election petition, this
time at the FedEx Freight service center in Pocono Summit, PA.
Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical
company focused on developing and commercializing a portfolio of
products for the critical care market, today announced that the Company
will host a conference call and live audio webcast on Wednesday,
December 17, 2014, at 8:30 a.m. ET to provide a corporate update and
discuss financial results for the second quarter fiscal year 2015 ended
October 31, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.